Text Size

Glaucoma Research Foundation Celebrates Public Launch of The Cure is in Sight Campaign during Annual Dinner

Glaucoma Research Foundation (GRF) hosted the 2017 Annual Dinner and public launch of The Cure is in Sight Campaign at the historic Julia Morgan Ballroom in the Financial District of San Francisco on April 25th, welcoming more than 120 guests including the Board of Directors, donors, and volunteers.

This year’s Annual Dinner included a special award to honor longtime philanthropists Frank Stein and the late Paul S. May. The centerpiece of the evening was a presentation on the discovery of new glaucoma biomarkers from the GRF-funded Catalyst for a Cure team of investigators: Alfred Dubra, PhD, Andrew G. Huberman, PhD, Jeffrey L. Goldberg, MD, PhD, and Vivek Srinivasan, PhD.


Dr. Robert Stamper (left) with GRF co-founder Dr. Jack Hetherington

Andrew Iwach, MD, GRF Board Chair, welcomed the newest member of the Board of Directors, John G. Flanagan, PhD, FCOptom, and honored Robert L. Stamper, MD (Vice Chair) for 30 years of dedicated service as a member of the GRF Board of Directors. Dr. Iwach also recognized Nobuko Saito Cleary and Gary Cleary, PharmD, PhD for their ongoing leadership and support as Co-chairs of the Gala for the last 10 years.

The Catalyst for a Cure team reported on their progress in the identification and validation of new glaucoma biomarkers, or biological measures, that will allow doctors to diagnose glaucoma earlier and treat it more effectively before vision is lost. Their research has now moved from the laboratory into the clinic for further testing on patients. In addition, the team reported that two new clinical trials are underway for vision restoration.


The CFC Research Team onstage with Thomas Brunner (right)

President and CEO, Thomas M. Brunner introduced The Cure is in Sight - The Campaign for Glaucoma Research Foundation and its ambitious goal of raising $15 million by June 2018, to coincide with Glaucoma Research Foundation’s 40th Anniversary. Mr. Brunner reported that more than $10 million has been raised during the Campaign’s quiet phase and thanked donors for their remarkable support to date.

To increase awareness about glaucoma and help reach the $15 million goal, Mr. Brunner reported that Glaucoma Research Foundation has launched a peer-to-peer fundraising website that will allow individuals or teams to raise money online. “We are very excited to offer an opportunity for patients and our donors to raise money and share their personal interest in glaucoma with their family and friends,” said Mr. Brunner. “The website is secure, easy to use, and all funds raised go directly to Glaucoma Research Foundation to benefit our programs.”


Fred Ross (right) performs with Mads Tolling

San Francisco Bay Area musicians Fred Ross and the Mads Tolling Quartet gave a lively musical performance to close out the celebratory evening, including a song made popular by the late Ray Charles, acclaimed singer-songwriter and musician who was blind from glaucoma.

Mr. Brunner noted: "This evening was a wonderful opportunity to recognize and thank our donors for their outstanding support and highlight the progress of our Catalyst for a Cure Biomarker Initiative."

"The Cure is in Sight Campaign is the largest fundraising endeavor in our history, and it will enable us to continue advancing glaucoma research and education. No one should go blind from glaucoma," he said.

Read more about Catalyst for a Cure collaborative research »

See photos from the 2017 Annual Dinner »

Last reviewed on January 06, 2021

This article appeared in the September 2017 issue of Gleams.


Was this helpful? Yes No